| Free radicals, reperfusion and myocardial infarction therapy: European Myocardial Infarction Project--free radicals pilot study. EMIP-FR Pilot Study Group. | |
| | |
MedLine Citation:
|
PMID: 8287869 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Reperfusion injury due to overproduction of free radicals may reduce the efficacy of thrombolytic therapy. Trimetazidine is an agent which could prevent or limit the deleterious effects of free radicals on the myocardium and could, therefore, improve the prognosis for patients with acute myocardial infarction (MI) receiving thrombolytic therapy. In this pilot study, 136 patients with suspected acute MI were randomized to receive either 40 mg trimetazidine as an intravenous (i.v.) bolus followed by an infusion of trimetazidine at 60 mg.24 h-1 for 48 h (n = 69) or matching placebo (n = 67). Stratification was based on the use ('T' stratum; n = 69) or not ('NT' stratum; n = 67) of a thrombolytic. The mean age of patients was 64.2 years (+/- 12.7), and the final diagnosis at discharge was confirmed MI in 92% of patients. No statistically significant difference was observed for the occurrence of major or minor adverse events. Eight patients died before discharge; three in the trimetazidine group and five in the placebo group. The observed compliance was good and the low rate of adverse events suggests that the study treatment can be considered safe in patients with suspected acute MI, either receiving thrombolytic treatment or not. The study is feasible and no major practical problem can be expected from this simple protocol. We started recruitment of patients for the large-scale mortality and morbidity trial in October 1992. |
| | |
Authors:
|
- |
Related Documents
:
|
19944389 - Same-day-discharge ad hoc percutaneous coronary intervention: initial single-centre exp... 20465719 - Paclitaxel-eluting stents for chronically occluded saphenous vein grafts (eos) study. 19781289 - Mechanisms and clinical significance of quality of final kissing balloon inflation in p... 21956049 - Long-term results of arthroscopic labral debridement: predictors of outcomes. 21895499 - Preoperative lateral subluxation of the patella is a predictor of poor early outcome of... 18261099 - Mohs micrographic surgery is accurate 95.1% of the time for melanoma in situ: a prospec... 22367569 - Transcatheter vs. surgical aortic valve replacement: a retrospective analysis assessing... 19463019 - Management of hypertension with the fixed combination of perindopril and amlodipine in ... 16157849 - Mosaicplasty with autogenous talar autograft for osteochondral lesions of the talus aft... |
Publication Detail:
|
Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial |
Journal Detail:
|
Title: European heart journal Volume: 14 Suppl G ISSN: 0195-668X ISO Abbreviation: Eur. Heart J. Publication Date: 1993 Nov |
Date Detail:
|
Created Date: 1994-02-24 Completed Date: 1994-02-24 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 8006263 Medline TA: Eur Heart J Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 48-51 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Double-Blind Method Female Free Radicals Humans Male Middle Aged Myocardial Infarction / drug therapy* Myocardial Reperfusion Injury / prevention & control* Myocardium / metabolism Pilot Projects Reactive Oxygen Species Thrombolytic Therapy* Trimetazidine / therapeutic use* |
| Chemical | |
Reg. No./Substance:
|
0/Free Radicals; 0/Reactive Oxygen Species; 5011-34-7/Trimetazidine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Thrombolysis: state of the art.
Next Document: Myocardial cytoprotection during percutaneous transluminal coronary angioplasty.